Promising therapy for patients with spinal cord injuries advances to the next stage Startupticker.ch
ONWARD, formerly known as GTX Medical, announced the enrollment of the first patient in a pivotal trial in the U.S. evaluating its ARC Therapy. The pivotal trial, known as Up-LIFT, will assess the safety and effectiveness of ARC Therapy in restoring hand and arm function in people with spinal cord injury. ONWARD is focused on developing and commercialising innovative therapies to facilitate functional recovery of people with spinal cord injury. Driven by a mission to restore movement, independence, and health in people with spinal cord injury, ONWARD developed the ARC Therapy, delivered by ...
Source: startupticker.ch